I prefer diversified high risk, high reward investing. Biotechs are a current favorite. In 2014, up 34.5% (117 times the S&P), and Stocktwits is a big reason. Happy with the result, but still cautious.
Shayne Heffernan holds a Ph.D. in Economics and brings with him over 25 years of trading experience in Asia and hands on experience in Venture Capital, he has been involved in several start ups that have seen market capitalization over $500m
Twits ideas 4 my personal use on Biotech & chart trades, but not recommendations on buy or sell.
I fail 99% of the time. You've been warned! Ideas Always be FREE. Follow me on twitter @BiotechMoney18 for more trade ideas.